GSK3β inhibitor TDZD8 ameliorates brain damage through both ROS scavenging and inhibition of apoptosis in hyperglycaemic subarachnoid haemorrhage rats

Clin Exp Pharmacol Physiol. 2022 Dec;49(12):1352-1360. doi: 10.1111/1440-1681.13723. Epub 2022 Sep 29.

Abstract

Hyperglycaemia is known to be associated with unfavourable outcomes in subarachnoid haemorrhage (SAH), but the pathogenic mechanism is unclear, and there is also a lack of effective therapeutic drugs in clinical practice. Phosphorylation of GSK3β at serine 9 can inhibit its activity to further worsen SAH. The aim of the present study was to evaluate the protective effect and the potential mechanism of the GSK3β inhibitor TDZD8 on brain injury in a hyperglycaemic SAH rat model. Hyperglycaemia was induced by intraperitoneal injection of streptozocin for 3 days. The SAH model was established by injecting fresh autologous femoral artery blood into the prechiasmatic cistern. p-GSK3β (Ser9) expression was induced by intraperitoneal injection of TDZD8 (30 min post-SAH). The expression levels of GSK3β, p-GSK3β, SOD1/2, caspase 3, Bax and Bcl-2 were detected by western blot analysis. Terminal deoxynucleotidyl transferase dUTP nick end-labelling (TUNEL) staining was used to detect neuronal apoptosis of basal temporal lobe. Neurological scores were calculated to determine behavioural recovery. Neuronal survival was detected by Nissl staining. Hyperglycaemia significantly decreased p-GSK3β expression, further exacerbated neurobehavioural deficits and increased oxidative stress and neuronal apoptosis in the brain after SAH compared to normal glycaemic SAH rats and hyperglycaemic rats. In addition, hyperglycaemic SAH rats had obvious oxidative stress and apoptosis. However, TDZD8 effectively decreased cleaved caspase 3 expression and TUNEL-positive cells and increased the Bcl2/Bax ratio, expression of SOD1/2 and activity of superoxide dismutase (SOD) enzyme compared with hyperglycaemic SAH rats. The GSK3β inhibitor TDZD8 has therapeutic potential for hyperglycaemic SAH. The neuroprotective effect of TDZD8 appears to be mediated through its antioxidative and antiapoptotic activity.

Keywords: GSK3β; TDZD8; hyperglycaemia; neuronal apoptosis; neuroprotection; oxidative stress; subarachnoid haemorrhage.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis
  • Brain / metabolism
  • Brain Injuries* / drug therapy
  • Caspase 3 / metabolism
  • Glycogen Synthase Kinase 3 beta / metabolism
  • Hyperglycemia* / pathology
  • Rats
  • Rats, Sprague-Dawley
  • Reactive Oxygen Species
  • Subarachnoid Hemorrhage* / complications
  • Superoxide Dismutase-1 / metabolism
  • Superoxide Dismutase-1 / pharmacology
  • Superoxide Dismutase-1 / therapeutic use
  • bcl-2-Associated X Protein / metabolism

Substances

  • Caspase 3
  • Glycogen Synthase Kinase 3 beta
  • Reactive Oxygen Species
  • bcl-2-Associated X Protein
  • Superoxide Dismutase-1